연구동향 분석

Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer

이용재 김다찬 김현수 나기용 이정윤 남은지 김상운 김성훈 김영태 2019년

논문상세정보
인용/피인용
' Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Next generation sequencing
  • ovarian cancer
  • targetable alterations
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
183 0

0.0%

' Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer' 의 참고문헌

  • Whole-genome characterization of chemoresistant ovarian cancer
    Patch AM [2015]
  • Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients : the Integrated Molecular Analysis of Cancer(IMAC)Study
    Heong V [2018]
  • Trends in gynecologic cancer mortality in East Asian regions
    이정윤 [2014]
  • The spectrum of clinical utilities in molecular pathology testing procedures for inherited conditions and cancer : a report of the Association for Molecular Pathology
    Joseph L [2016]
  • The Cancer Genome Atlas Pan-Cancer analysis project
  • Standards and guidelines for the interpretation and reporting of sequence variants in cancer : A joint consensus recommendation of the association for molecular pathology, American Society of Clinical Oncology, and College of American pathologists
    Li MM [2017]
  • Significance of multiple mutations in cancer
    Loeb KR [2000]
  • Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas
    Norquist B [2011]
  • Prognostic factors for stage III epithelial ovarian cancer : a Gynecologic Oncology Group Study
  • Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
  • Integrated genomic characterization of endometrial carcinoma
  • Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010
    임명철 [2013]
  • Implementation of next generation sequencing into pediatric hematology-oncology practice : moving beyond actionable alterations
    Oberg JA [2016]
  • Defining actionable mutations for oncology therapeutic development
    Carr TH [2016]
  • Clinical validation and implementation of a targeted nextgeneration sequencing assay to detect somatic variants in nonsmall cell lung, melanoma, and gastrointestinal malignancies
    Fisher KE [2016]
  • Clinical next-generation sequencing for precision oncology in rare cancers
    Groisberg R [2018]